Invention Grant
- Patent Title: Solubilized magnolol analogs
- Patent Title (中): 溶解的木兰酚类似物
-
Application No.: US14362892Application Date: 2011-12-15
-
Publication No.: US09155693B2Publication Date: 2015-10-13
- Inventor: Regina Hourigan , Jeffrey Mastrull , Jairajh Mattai , James Masters
- Applicant: Regina Hourigan , Jeffrey Mastrull , Jairajh Mattai , James Masters
- Applicant Address: US NY New York
- Assignee: Colgate-Palmolive Company
- Current Assignee: Colgate-Palmolive Company
- Current Assignee Address: US NY New York
- International Application: PCT/US2011/065020 WO 20111215
- International Announcement: WO2013/089718 WO 20130620
- Main IPC: A61K36/575
- IPC: A61K36/575 ; A61Q11/00 ; A61Q19/00 ; A61K8/86 ; A61K8/34 ; A61K8/39 ; A61Q19/10 ; A61K8/21 ; A61K8/25 ; A61K8/29 ; A61K8/41 ; A61K8/46 ; A61K8/60 ; A61K8/84
Abstract:
A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol, and PPG-1-PEG-9 lauryl glycol ether. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators.
Public/Granted literature
- US20140348761A1 SOLUBILIZED MAGNOLOL ANALOGS Public/Granted day:2014-11-27
Information query
